A research paper by scientists at The Hong Kong Polytechnic University developed an electromyography (EMG)-driven soft robot with electro-vibro-feedback (EVF-robot) for targeted somatosensory priming in W/H muscles.

A research paper by scientists at Shenzhen Institutes of Advanced Technology presented the Marker-GMformer model, a marker trajectories-driven deep learning model designed for efficient and accurate continuous prediction of lower limb kinematics and dynamics.

February 10, 2026 – Insilico Medicine (“Insilico”, 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited (“CMS”, 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, today announced a series of AI‑empowered drug discovery collaborations across multiple projects in the fields of central nervous system and autoimmune diseases.

The ways people interact with and view nature speak volumes as to how the Earth is treated, and the severity of environmental concerns rising makes what shapes people’s view of nature a pertinent topic. Understanding how and why people might be motivated to protect nature is no small feat. Researchers have been able to present a study on 745 Japanese participants using three types of nature’s value—intrinsic, relational, and instrumental—to categorize a method to fully appreciate what goes into the construction of a human’s relationship with nature.

In a significant breakthrough for cancer immunotherapy, collaborative studies published simultaneously in Immunity & Inflammation and Nature have demonstrated a critical molecular mechanism that drives CD8⁺ T cells into a dysfunctional “exhausted” state within tumors. The studies reveal how chronic antigen exposure opens a molecular switch—the suppression of the FOXO1-KLHL6 axis—to promote T cells toward exhaustion, providing a promising new target for intervention.

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that molecular changes in subchondral bone occur earlier and can signal disease progression before cartilage loss. Using spatial mass spectrometry imaging and synovial fluid proteomics, researchers identified bone-derived protein signatures beneath intact cartilage that were also detectable in joint fluid. These findings point to promising, less invasive biomarkers for earlier diagnosis and improved monitoring of osteoarthritis progression.